Related Experiment Video
Updated: Jan 12, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
Iatrogenic Botulism Following Unregulated Cosmetic Botulinum Toxin Injection
1Accident and Emergency, Hinchingbrooke Hospital, Huntingdon, GBR.
Abstract:
We report the case of a 35-year-old woman who developed progressive neuromuscular weakness, bulbar symptoms, and dysphagia following administration of unlicensed cosmetic botulinum toxin at home by a non-medical acquaintance. Her husband, who received injections from the same vial, was admitted to intensive care and required intubation. Our patient required close airway monitoring, antitoxin therapy, immunoglobulins, and multidisciplinary support, but did not require ventilatory support. She gradually improved and was discharged with ongoing outpatient neurology and speech therapy follow-up. This case highlights the dangers of unregulated access to botulinum toxin, the importance of early recognition of iatrogenic botulism, and the role of public health reporting in preventing further harm.
More Related Videos
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Prevention of Further Absorption of Poison
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Depolarizing Blockers: Pharmocokinetics

